Leo Groenewegen
Vorstandsvorsitzender bei NBAB, Nordic BioAnalysis AB
Profil
Leo Groenewegen is currently the Chief Executive Officer at NBAB, Nordic BioAnalysis AB.
Prior to this, he worked as the Chief Financial Officer at NextCell Pharma AB.
Aktive Positionen von Leo Groenewegen
| Unternehmen | Position | Beginn |
|---|---|---|
NBAB, Nordic BioAnalysis AB
 NBAB, Nordic BioAnalysis AB BiotechnologyHealth Technology Part of Ilya Pharma AB, NBAB, Nordic BioAnalysis AB engages in bio analytical development, validation and analysis of medicines. The company is based in Södertälje, Sweden. The Swedish company was founded in 2010. The CEO is Leo Groenewegen. NBAB was acquired by Ilya Pharma AB on April 19, 2022. | Vorstandsvorsitzender | 01.09.2022 |
Ehemalige bekannte Positionen von Leo Groenewegen
| Unternehmen | Position | Ende |
|---|---|---|
| NEXTCELL PHARMA AB | Finanzdirektor/CFO | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NEXTCELL PHARMA AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
NBAB, Nordic BioAnalysis AB
NBAB, Nordic BioAnalysis AB BiotechnologyHealth Technology Part of Ilya Pharma AB, NBAB, Nordic BioAnalysis AB engages in bio analytical development, validation and analysis of medicines. The company is based in Södertälje, Sweden. The Swedish company was founded in 2010. The CEO is Leo Groenewegen. NBAB was acquired by Ilya Pharma AB on April 19, 2022. | Health Technology |